Geneos Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $339K | Sell |
13,924
-7,476
| -35% | -$182K | 0.01% | 823 |
|
|
2025
Q1 | $444K | Buy |
21,400
+10,700
| +100% | +$222K | 0.01% | 935 |
|
|
2024
Q4 | $252K | Hold |
10,700
| – | – | 0.01% | 768 |
|
|
2024
Q3 | $274K | Buy |
10,700
+1,135
| +12% | +$29.1K | 0.01% | 689 |
|
|
2024
Q2 | $225K | Sell |
9,565
-146
| -2% | -$3.43K | 0.01% | 678 |
|
|
2024
Q1 | $279K | Sell |
9,711
-15
| -0.2% | -$431 | 0.01% | 620 |
|
|
2023
Q4 | $319K | Buy |
9,726
+1,677
| +21% | +$55K | 0.02% | 565 |
|
|
2023
Q3 | $224K | Hold |
8,049
| – | – | 0.01% | 654 |
|
|
2023
Q2 | $274K | Buy |
8,049
+35
| +0.4% | +$1.19K | 0.01% | 604 |
|
|
2023
Q1 | $241K | Buy |
8,014
+1,394
| +21% | +$41.9K | 0.01% | 611 |
|
|
2022
Q4 | $187K | Sell |
6,620
-39,854
| -86% | -$1.13M | 0.01% | 639 |
|
|
2022
Q3 | $1.53M | Sell |
46,474
-366
| -0.8% | -$12K | 0.11% | 195 |
|
|
2022
Q2 | $1.54M | Sell |
46,840
-29
| -0.1% | -$950 | 0.08% | 240 |
|
|
2022
Q1 | $2.15M | Buy |
46,869
+10,212
| +28% | +$469K | 0.09% | 213 |
|
|
2021
Q4 | $2.24M | Sell |
36,657
-217
| -0.6% | -$13.3K | 0.09% | 239 |
|
|
2021
Q3 | $2.76M | Buy |
36,874
+2,648
| +8% | +$198K | 0.11% | 198 |
|
|
2021
Q2 | $3.15M | Sell |
34,226
-560
| -2% | -$51.5K | 0.12% | 183 |
|
|
2021
Q1 | $3.09M | Sell |
34,786
-433
| -1% | -$38.5K | 0.09% | 230 |
|
|
2020
Q4 | $2.98M | Buy |
35,219
+9,677
| +38% | +$819K | 0.12% | 185 |
|
|
2020
Q3 | $1.59M | Buy |
25,542
+10,550
| +70% | +$658K | 0.08% | 231 |
|
|
2020
Q2 | $757K | Hold |
14,992
| – | – | 0.04% | 327 |
|
|
2020
Q1 | $470K | Buy |
+14,992
| New | +$470K | 0.03% | 385 |
|